Logo image of CLA.PA

CLARANOVA SE (CLA.PA) Stock Fundamental Analysis

EPA:CLA - Euronext Paris - Matif - FR0013426004 - Common Stock - Currency: EUR

1.42  +0.02 (+1.57%)

Fundamental Rating

4

CLA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 98 industry peers in the Software industry. While CLA is still in line with the averages on profitability rating, there are concerns on its financial health. CLA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CLA has reported negative net income.
CLA had a positive operating cash flow in the past year.
In multiple years CLA reported negative net income over the last 5 years.
Each year in the past 5 years CLA had a positive operating cash flow.
CLA.PA Yearly Net Income VS EBIT VS OCF VS FCFCLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

CLA's Return On Assets of -4.90% is on the low side compared to the rest of the industry. CLA is outperformed by 71.26% of its industry peers.
With an excellent Return On Invested Capital value of 25.41%, CLA belongs to the best of the industry, outperforming 94.25% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CLA is significantly above the industry average of 11.66%.
The last Return On Invested Capital (25.41%) for CLA is above the 3 year average (17.80%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -4.9%
ROE N/A
ROIC 25.41%
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.8%
ROIC(5y)14.17%
CLA.PA Yearly ROA, ROE, ROICCLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

CLA has a Operating Margin (8.23%) which is in line with its industry peers.
CLA's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 28.55%, CLA is doing worse than 89.66% of the companies in the same industry.
In the last couple of years the Gross Margin of CLA has grown nicely.
Industry RankSector Rank
OM 8.23%
PM (TTM) N/A
GM 28.55%
OM growth 3Y17.26%
OM growth 5Y13.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
CLA.PA Yearly Profit, Operating, Gross MarginsCLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

2

2. Health

2.1 Basic Checks

CLA has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CLA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CLA has been increased compared to 5 years ago.
Compared to 1 year ago, CLA has an improved debt to assets ratio.
CLA.PA Yearly Shares OutstandingCLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLA.PA Yearly Total Debt VS Total AssetsCLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 1.39, we must say that CLA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CLA (1.39) is worse than 70.11% of its industry peers.
The Debt to FCF ratio of CLA is 4.39, which is a neutral value as it means it would take CLA, 4.39 years of fcf income to pay off all of its debts.
CLA has a Debt to FCF ratio (4.39) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.39
Altman-Z 1.39
ROIC/WACC3.62
WACC7.02%
CLA.PA Yearly LT Debt VS Equity VS FCFCLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.75 indicates that CLA may have some problems paying its short term obligations.
CLA has a worse Current ratio (0.75) than 89.66% of its industry peers.
CLA has a Quick Ratio of 0.75. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
CLA has a worse Quick ratio (0.61) than 93.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.61
CLA.PA Yearly Current Assets VS Current LiabilitesCLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

CLA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.97%.
CLA shows a decrease in Revenue. In the last year, the revenue decreased by -2.23%.
Measured over the past years, CLA shows a quite strong growth in Revenue. The Revenue has been growing by 13.58% on average per year.
EPS 1Y (TTM)4.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.29%
Revenue 1Y (TTM)-2.23%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%1.25%

3.2 Future

CLA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.50% yearly.
Based on estimates for the next years, CLA will show a small growth in Revenue. The Revenue will grow by 3.71% on average per year.
EPS Next Y41.18%
EPS Next 2Y26.49%
EPS Next 3Y25.5%
EPS Next 5YN/A
Revenue Next Year0.15%
Revenue Next 2Y3.22%
Revenue Next 3Y3.71%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLA.PA Yearly Revenue VS EstimatesCLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CLA.PA Yearly EPS VS EstimatesCLA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

6

4. Valuation

4.1 Price/Earnings Ratio

CLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CLA is valuated cheaply with a Price/Forward Earnings ratio of 4.69.
Based on the Price/Forward Earnings ratio, CLA is valued cheaper than 96.55% of the companies in the same industry.
CLA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.74.
Industry RankSector Rank
PE N/A
Fwd PE 4.69
CLA.PA Price Earnings VS Forward Price EarningsCLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

CLA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CLA is cheaper than 94.25% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLA indicates a rather cheap valuation: CLA is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.35
EV/EBITDA 3.67
CLA.PA Per share dataCLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

CLA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLA's earnings are expected to grow with 25.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.49%
EPS Next 3Y25.5%

0

5. Dividend

5.1 Amount

No dividends for CLA!.
Industry RankSector Rank
Dividend Yield N/A

CLARANOVA SE

EPA:CLA (2/5/2025, 2:03:08 PM)

1.42

+0.02 (+1.57%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13 2024-11-13
Earnings (Next)N/A N/A
Inst Owners19.07%
Inst Owner ChangeN/A
Ins Owners16.66%
Ins Owner ChangeN/A
Market Cap81.24M
Analysts74.29
Price Target3.33 (134.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)4.9%
EPS NY rev (3m)4.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.46%
Revenue NY rev (3m)-2.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.69
P/S 0.16
P/FCF 2.35
P/OCF 2.05
P/B N/A
P/tB N/A
EV/EBITDA 3.67
EPS(TTM)-0.22
EYN/A
EPS(NY)0.3
Fwd EY21.34%
FCF(TTM)0.6
FCFY42.47%
OCF(TTM)0.69
OCFY48.87%
SpS8.66
BVpS-0.17
TBVpS-2.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.9%
ROE N/A
ROCE 34.58%
ROIC 25.41%
ROICexc 37.02%
ROICexgc N/A
OM 8.23%
PM (TTM) N/A
GM 28.55%
FCFM 6.96%
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.8%
ROIC(5y)14.17%
ROICexc(3y)47.12%
ROICexc(5y)37.42%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)24.22%
ROCE(5y)19.28%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y5.74%
ROICexc growth 5Y11.68%
OM growth 3Y17.26%
OM growth 5Y13.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
F-Score5
Asset Turnover2.17
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.39
Debt/EBITDA 2.31
Cap/Depr 42.98%
Cap/Sales 1.05%
Interest Coverage 250
Cash Conversion 75.05%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.61
Altman-Z 1.39
F-Score5
WACC7.02%
ROIC/WACC3.62
Cap/Depr(3y)51.75%
Cap/Depr(5y)41.72%
Cap/Sales(3y)1.22%
Cap/Sales(5y)0.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.29%
EPS Next Y41.18%
EPS Next 2Y26.49%
EPS Next 3Y25.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.23%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%1.25%
Revenue Next Year0.15%
Revenue Next 2Y3.22%
Revenue Next 3Y3.71%
Revenue Next 5YN/A
EBIT growth 1Y56.92%
EBIT growth 3Y19.3%
EBIT growth 5Y28.47%
EBIT Next Year39.46%
EBIT Next 3Y19.79%
EBIT Next 5YN/A
FCF growth 1Y2256.25%
FCF growth 3Y32.3%
FCF growth 5Y48.99%
OCF growth 1Y326.88%
OCF growth 3Y28.52%
OCF growth 5Y40.7%